国家药监局：药品网售平台要不断压实主体责任

Core Viewpoint - The National Medical Products Administration (NMPA) emphasizes the need for enhanced regulation of online pharmaceutical sales platforms to ensure public safety in medication use [1] Group 1: Regulatory Measures - The NMPA held an administrative guidance meeting to address prominent issues identified in the monitoring of online drug sales [1] - The meeting included feedback from local drug regulatory authorities regarding the management of online pharmaceutical sales platforms [1] Group 2: Responsibilities and Management - Online drug sales platforms are urged to strengthen their primary responsibilities and improve internal professional management and process optimization [1] - There is a call for better management of merchants on these platforms, including the establishment of a comprehensive risk consultation mechanism [1] Group 3: Monitoring and Safety - The NMPA highlighted the importance of optimizing intelligent monitoring tools and cooperating with regulatory bodies for effective monitoring and governance [1] - The ultimate goal is to ensure the safety of public medication use through these enhanced regulatory efforts [1]